UnitedHealth Group Incorporated $UNH Shares Sold by EP Wealth Advisors LLC

by · The Cerbat Gem

EP Wealth Advisors LLC cut its position in UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 0.5% in the 1st quarter, Holdings Channel.com reports. The firm owned 83,141 shares of the healthcare conglomerate’s stock after selling 403 shares during the quarter. EP Wealth Advisors LLC’s holdings in UnitedHealth Group were worth $43,545,000 as of its most recent SEC filing.

Several other institutional investors have also recently added to or reduced their stakes in the stock. Capital Investment Counsel LLC raised its holdings in UnitedHealth Group by 1.9% in the first quarter. Capital Investment Counsel LLC now owns 14,755 shares of the healthcare conglomerate’s stock valued at $7,728,000 after acquiring an additional 277 shares in the last quarter. Maverick Capital Ltd. acquired a new stake in UnitedHealth Group in the first quarter valued at $76,948,000. Focus Partners Advisor Solutions LLC raised its holdings in UnitedHealth Group by 23.2% in the first quarter. Focus Partners Advisor Solutions LLC now owns 13,347 shares of the healthcare conglomerate’s stock valued at $6,990,000 after acquiring an additional 2,515 shares in the last quarter. First Financial Bankshares Inc raised its holdings in UnitedHealth Group by 2.4% in the first quarter. First Financial Bankshares Inc now owns 39,111 shares of the healthcare conglomerate’s stock valued at $20,484,000 after acquiring an additional 918 shares in the last quarter. Finally, Ameriflex Group Inc. raised its holdings in UnitedHealth Group by 143.9% in the first quarter. Ameriflex Group Inc. now owns 1,846 shares of the healthcare conglomerate’s stock valued at $967,000 after acquiring an additional 1,089 shares in the last quarter. 87.86% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of analysts have weighed in on UNH shares. Bank of America increased their target price on shares of UnitedHealth Group from $290.00 to $325.00 and gave the stock a “neutral” rating in a report on Monday, August 18th. UBS Group reiterated a “buy” rating on shares of UnitedHealth Group in a research report on Thursday, July 17th. Robert W. Baird restated an “underperform” rating and set a $198.00 price objective (down previously from $312.00) on shares of UnitedHealth Group in a research report on Thursday, July 31st. TD Cowen lowered shares of UnitedHealth Group from a “buy” rating to a “hold” rating and set a $308.00 price objective for the company. in a research report on Monday, May 19th. Finally, Morgan Stanley reduced their price objective on shares of UnitedHealth Group from $342.00 to $325.00 and set an “overweight” rating for the company in a research report on Wednesday, August 20th. Fifteen equities research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $353.00.

Read Our Latest Stock Analysis on UnitedHealth Group

UnitedHealth Group Price Performance

UNH stock opened at $309.77 on Tuesday. The firm has a 50-day moving average of $288.34 and a two-hundred day moving average of $378.14. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.73. The firm has a market capitalization of $280.55 billion, a PE ratio of 13.42, a P/E/G ratio of 2.00 and a beta of 0.44. UnitedHealth Group Incorporated has a one year low of $234.60 and a one year high of $630.73.

UnitedHealth Group (NYSE:UNH – Get Free Report) last posted its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $4.45 by ($0.37). The company had revenue of $111.62 billion during the quarter, compared to analysts’ expectations of $111.75 billion. UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.UnitedHealth Group’s revenue for the quarter was up 12.9% compared to the same quarter last year. During the same period last year, the company earned $6.80 earnings per share. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. On average, analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 23rd. Investors of record on Monday, September 15th will be given a dividend of $2.21 per share. This represents a $8.84 annualized dividend and a yield of 2.9%. The ex-dividend date of this dividend is Monday, September 15th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 38.30%.

Insiders Place Their Bets

In related news, CEO Patrick Hugh Conway sold 589 shares of the firm’s stock in a transaction that occurred on Tuesday, June 10th. The shares were sold at an average price of $305.00, for a total transaction of $179,645.00. Following the transaction, the chief executive officer owned 10,398 shares of the company’s stock, valued at approximately $3,171,390. This trade represents a 5.36% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Insiders own 0.28% of the company’s stock.

UnitedHealth Group Company Profile

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Featured Articles

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).